Inventor · disambiguated record
Candelaria Gomez-Manzano
Also filed as: GOMEZ-MANZANO CANDELARIA
9 granted patents·11 pending applications·63 citations·filing 2002–2024
87Inventor score
Top patents by PatentIndex Score
20 records- 0191US10080774B2Oncolytic adenovirus armed with therapeutic genesUNIV TEXAS·Filed 2015·Granted Sep 25, 2018·10 cites·13 claims
- 0289US9061055B2Oncolytic adenovirus armed with therapeutic genesFUEYO JUAN·Filed 2009·Granted Jun 23, 2015·12 cites·10 claims
- 0388US8168168B2Infectivity-enhanced conditionally-replicative adenovirus and uses thereofFUEYO JUAN·Filed 2009·Granted May 1, 2012·17 cites·1 claims
- 0487US7354582B2Use of VEGF antagonists for the treatment of malignant gliomasREGENERON PHARMA·Filed 2006·Granted Apr 8, 2008·13 cites·12 claims
- 0585US10391183B2Infectivity-enhanced conditionally-replicative adenovirus and uses thereofUNIV TEXAS·Filed 2014·Granted Aug 27, 2019·8 cites·8 claims
- 0682US2025171745A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2024·Application pending·0 cites
- 0774US11155599B2Adenoviruses expressing heterologous tumor-associated antigensUNIV TEXAS·Filed 2013·Granted Oct 26, 2021·1 cites·17 claims
- 0873US11090344B2Adenovirus and immunomodulator combination therapyDNATRIX INC·Filed 2017·Granted Aug 17, 2021·1 cites·14 claims
- 0968US2021301264A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2021·Application pending·0 cites
- 1067US11065285B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2020·Granted Jul 20, 2021·0 cites·14 claims
- 1161US10238698B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNA TRIX INC·Filed 2013·Granted Mar 26, 2019·1 cites·6 claims
- 1260US2021213079A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2021·Application pending·0 cites
- 1358US2016289645A1Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)DNATRIX INC·Filed 2014·Application pending·0 cites
- 1456US2019093085A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2018·Application pending·0 cites
- 1556US2006147420A1Oncolytic adenovirus armed with therapeutic genesFUEYO JUAN·Filed 2005·Application pending·0 cites
- 1653US2012207711A1Infectivity-enhanced conditionally-replicative adenovirus and uses thereofFUEYO JUAN·Filed 2012·Application pending·0 cites
- 1752US2007292396A1Combination therapy with oncolytic adenovirusFUEYO JUAN·Filed 2007·Application pending·0 cites
- 1852US2019269744A1Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2019·Application pending·0 cites
- 1948US2003138405A1Conditionally replicative adenovirus to target the Rb and Rb-related pathwaysFiled 2002·Application pending·0 cites
- 2046US2005260162A1Conditionally replicative adenovirus to target the Rb and Rb-related pathwaysFUEYO JUAN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Candelaria Gomez-Manzano files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →